Neurocrine Biosciences Inc (NAS:NBIX)
$ 140.98 -1.02 (-0.72%) Market Cap: 14.19 Bil Enterprise Value: 13.59 Bil PE Ratio: 38.84 PB Ratio: 5.94 GF Score: 89/100

Q3 2019 Neurocrine Biosciences Inc Earnings Call Transcript

Nov 04, 2019 / 09:30PM GMT
Release Date Price: $102.42 (-1.20%)
Operator

Good day, everyone, and welcome to the Neurocrine Biosciences Third Quarter 2019 Results Call. (Operator Instructions) Today's program is being recorded, and I will be standing by if you should need any assistance. It is now my pleasure to turn today's conference over to the CEO of Neurocrine Biosciences, Kevin Gorman.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

Thank you, and welcome, everyone, to our earnings call. I'm joined today by Matt Abernethy, our Chief Financial Officer; Eiry Roberts, our Chief Medical Officer; Eric Benevich, our Chief Commercial Officer; Kyle Gano, our Chief Business Development and Strategy Officer; and

(technical difficulty)

of Investor Relations.

Before we begin, I'd like to ask Todd to read our safe harbor statement.

Todd Tushla
Neurocrine Biosciences, Inc. - VP of IR

Yes. So good afternoon, everyone. Certain statements made in the course of this conference call that are not historical statements may be forward-looking statements,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot